Other Non-Current Liabilities
Albemarle Other Non-Current Liabilities increased by 3.1% to $1.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $1.13B to $1.12B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 11.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $616.91M | $617.49M | $663.70M | $649.88M | $591.02M | $597.98M | $636.60M | $686.66M | $700.83M | $807.05M | $769.10M | $833.55M | $758.28M | $791.82M | $819.20M | $1.13B | $1.14B | $1.14B | $1.08B | $1.12B |
| QoQ Change | — | +0.1% | +7.5% | -2.1% | -9.1% | +1.2% | +6.5% | +7.9% | +2.1% | +15.2% | -4.7% | +8.4% | -9.0% | +4.4% | +3.5% | +37.4% | +1.7% | -0.7% | -4.6% | +3.1% |
| YoY Change | — | — | — | — | -4.2% | -3.2% | -4.1% | +5.7% | +18.6% | +35.0% | +20.8% | +21.4% | +8.2% | -1.9% | +6.5% | +35.1% | +51.0% | +43.6% | +32.4% | -0.7% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Albemarle's other non-current liabilities?
- Albemarle (ALB) reported other non-current liabilities of $1.12B in Q1 2026.
- How has Albemarle's other non-current liabilities changed year-over-year?
- Albemarle's other non-current liabilities decreased by 0.7% year-over-year, from $1.13B to $1.12B.
- What is the long-term trend for Albemarle's other non-current liabilities?
- Over 5 years (2020 to 2025), Albemarle's other non-current liabilities has grown at a 11.5% compound annual growth rate (CAGR), from $629.38M to $1.08B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.